HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

T Maeda Selected Research

Hemolysis

9/2001Blood trauma induced by clinically accepted oxygenators.
9/2001Direct detection of red blood cell fragments: a new flow cytometric method to evaluate hemolysis in blood pumps.
7/2000Preclinical evaluation of a hollow fiber silicone membrane oxygenator for extracorporeal membrane oxygenator application.
1/2000Distribution of the intermedilysin gene among the anginosus group streptococci and correlation between intermedilysin production and deep-seated infection with Streptococcus intermedius.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


T Maeda Research Topics

Disease

28Neoplasms (Cancer)
01/2017 - 02/2000
9Infections
11/2021 - 01/2000
6Carcinoma (Carcinomatosis)
01/2017 - 02/2000
5Leukemia
08/2013 - 04/2000
5Breast Neoplasms (Breast Cancer)
03/2006 - 03/2000
4Rheumatoid Arthritis
12/2021 - 01/2000
4Inflammation (Inflammations)
04/2018 - 02/2001
4Body Weight (Weight, Body)
01/2016 - 01/2000
4Acute Myeloid Leukemia (Acute Myelogenous Leukemia)
06/2012 - 08/2000
4Neoplasm Metastasis (Metastasis)
03/2011 - 01/2000
4Hemorrhage
12/2007 - 02/2000
4Hepatocellular Carcinoma (Hepatoma)
10/2001 - 03/2000
4Ocular Paraneoplastic Syndromes
10/2001 - 04/2000
4Adult T-Cell Leukemia-Lymphoma (Leukemia Lymphoma, T Cell, Acute, HTLV I Associated)
09/2001 - 05/2000
4Hemolysis
09/2001 - 01/2000
3Melanoma (Melanoma, Malignant)
01/2022 - 01/2019
3Thrombosis (Thrombus)
09/2014 - 05/2000
3Hypoxia (Hypoxemia)
07/2011 - 02/2000
3Hypertension (High Blood Pressure)
03/2011 - 01/2000
3Ischemia
01/2007 - 03/2000
3Osteoporosis
03/2006 - 03/2000
3Lymphoma (Lymphomas)
10/2001 - 04/2000
3Wounds and Injuries (Trauma)
09/2001 - 07/2000
2Periodontitis
05/2017 - 04/2014
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2017 - 12/2000
2Esophageal Neoplasms (Esophageal Cancer)
01/2015 - 04/2001
2Pneumonia (Pneumonitis)
08/2012 - 08/2001
2Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia)
05/2012 - 05/2000
2Necrosis
01/2012 - 01/2001
2Pain (Aches)
04/2011 - 01/2000
2Coronary Disease (Coronary Heart Disease)
02/2009 - 03/2006
2Asthma (Bronchial Asthma)
11/2008 - 02/2008
2Endometrial Neoplasms (Endometrial Cancer)
07/2005 - 04/2000
2Adenocarcinoma of Lung
03/2001 - 04/2000
2Paraneoplastic Syndromes (Paraneoplastic Syndrome)
02/2001 - 04/2000
2Seizures (Absence Seizure)
05/2000 - 03/2000
1Keloid
02/2021
1Hemangiosarcoma (Angiosarcoma)
11/2020
1Granulomatosis with Polyangiitis (Wegener's Granulomatosis)
07/2020

Drug/Important Bio-Agent (IBA)

7Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2001
7DNA (Deoxyribonucleic Acid)IBA
11/2001 - 04/2000
4Therapeutic UsesIBA
12/2017 - 03/2000
4RecoverinIBA
10/2001 - 04/2000
4Retinaldehyde (Retinal)IBA
10/2001 - 04/2000
3NivolumabIBA
01/2022 - 01/2019
3Peptides (Polypeptides)IBA
07/2021 - 11/2001
3Biomarkers (Surrogate Marker)IBA
03/2021 - 01/2005
3Glucose (Dextrose)FDA LinkGeneric
06/2019 - 02/2000
3Pharmaceutical PreparationsIBA
08/2017 - 10/2004
3AntibodiesIBA
01/2007 - 01/2000
3AutoantigensIBA
05/2003 - 03/2001
2AutoantibodiesIBA
12/2021 - 02/2001
2Doxorubicin (Adriamycin)FDA LinkGeneric
11/2020 - 03/2001
2taxaneIBA
11/2020 - 10/2019
2Fibrinogen (Factor I)FDA Link
07/2020 - 10/2000
2Messenger RNA (mRNA)IBA
05/2017 - 10/2000
2Dopamine (Intropin)FDA LinkGeneric
06/2015 - 02/2000
2NF-kappa B (NF-kB)IBA
01/2015 - 08/2014
2Reactive Oxygen Species (Oxygen Radicals)IBA
04/2014 - 11/2000
2NucleotidesIBA
11/2012 - 01/2001
2Pyridinolcarbamate (P23)IBA
06/2012 - 03/2012
2Anabolic AgentsIBA
11/2008 - 01/2001
2AntigensIBA
02/2008 - 04/2000
2Immunoglobulin E (IgE)IBA
10/2006 - 05/2003
2Histone Deacetylase InhibitorsIBA
06/2006 - 12/2000
2SuspensionsIBA
03/2006 - 03/2001
2CholesterolIBA
03/2006 - 01/2000
2EpitopesIBA
05/2003 - 02/2001
2SteroidsIBA
06/2002 - 03/2000
2Ganciclovir (Cytovene)FDA LinkGeneric
11/2001 - 03/2001
2Thymidine KinaseIBA
11/2001 - 03/2001
2Ethanol (Ethyl Alcohol)IBA
10/2001 - 07/2000
2Anti-Infective Agents (Microbicides)IBA
10/2001 - 08/2000
2Insulin (Novolin)FDA Link
08/2001 - 01/2000
2CytokinesIBA
07/2001 - 02/2000
2GelatinIBA
03/2001 - 05/2000
2LipopolysaccharidesIBA
02/2001 - 10/2000
2Nitric Oxide (Nitrogen Monoxide)FDA Link
03/2000 - 01/2000
1Carboplatin (JM8)FDA LinkGeneric
01/2022
1IpilimumabIBA
01/2022
1Paclitaxel (Taxol)FDA LinkGeneric
01/2022
1Anti-Citrullinated Protein AntibodiesIBA
12/2021
1phenothiazineIBA
11/2021
1Indocyanine Green (Cardio-Green)FDA LinkGeneric
03/2021
1eribulinFDA Link
11/2020
1Taxoids (Taxanes)IBA
11/2020
1Complement Factor D (Factor D)IBA
07/2020
1Complement Factor H (Factor H)IBA
07/2020
1Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
07/2020
1Complement C3b (C3bi)IBA
07/2020

Therapy/Procedure

10Therapeutics
01/2022 - 07/2000
6Drug Therapy (Chemotherapy)
10/2019 - 12/2000
4Hepatectomy
12/2002 - 01/2000
3Hematopoietic Stem Cell Transplantation
05/2012 - 01/2005
3Bone Marrow Transplantation (Transplantation, Bone Marrow)
06/2003 - 08/2000
2Aftercare (After-Treatment)
02/2021 - 05/2017
2Ligation
05/2017 - 01/2012
2Transplantation
01/2005 - 09/2000
2Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)
06/2003 - 05/2000
2Oxygenators
09/2001 - 07/2000